Related references
Note: Only part of the references are listed.FGF23 Elevation and Hypophosphatemia after Intravenous Iron Polymaltose: A Prospective Study
Belinda J. Schouten et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease:: The ferric carboxymaltose (FERINJECT®) randomized controlled trial
Stefanie Kulnigg et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Ferumoxytol for Treating Iron Deficiency Anemia in CKD
Bruce S. Spinowitz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes
Lynda A. Szczech et al.
KIDNEY INTERNATIONAL (2008)
Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia - A randomized controlled trial
David B. Van Wyck et al.
OBSTETRICS AND GYNECOLOGY (2007)
Update on adverse drug events associated with parenteral iron
GM Chertow et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
A Randomized controlled trial of oral versus intravenous iron in chronic kidney disease
Rajiv Agarwal et al.
AMERICAN JOURNAL OF NEPHROLOGY (2006)
Iron deficiency in patients with chronic kidney disease: potential role for intravenous iron therapy independent of erythropoietin
James B. Post et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2006)
A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD
DB Van Wyck et al.
KIDNEY INTERNATIONAL (2005)
Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease -: A randomized, controlled, open-label, multicenter study
O Schröder et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Hypersensitivity reactions and deaths associated with intravenous iron preparations
GR Bailie et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2005)
Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis
C Charytan et al.
NEPHRON CLINICAL PRACTICE (2005)
Chronic use of sodium ferric gluconate complex in hemodialysis patients:: Safety of higher-dose (≥250 mg) administration
VW Folkert et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Incidence of side-effects associated with high-dose ferric gluconate in patients with severe chronic renal failure
B Bastani et al.
NEPHROLOGY (2003)
Controversies in iron management
AR Nissenson et al.
KIDNEY INTERNATIONAL (2003)
Iron status and hemoglobin level in chronic renal insufficiency
CY Hsu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Intravenous iron sucrose: Establishing a safe dose
G Chandler et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2001)
A randomized study of oral vs intravenous iron supplementation in patients with progressive renal insufficiency treated with erythropoietin
J Stoves et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2001)
Oral repletion of iron induces free radical mediated alterations in the gastrointestinal tract of rat
K Srigiridhar et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2001)
Severe hypophosphatemia during hematopoietic reconstitution after allogeneic peripheral blood stem cell transplantation
M Steiner et al.
BONE MARROW TRANSPLANTATION (2000)
Share Paper
